The abstract is read at the publisher; the summary is JClub's.
AAV-STITCH covalently couples an anti-GD2 scFv to an AAV9-W503A capsid, enabling selective transduction of GD2-expressing neuroblastoma cells with no healthy liver transduction in pseudometastatic xenografts.
- Why it matters: Broad AAV tropism limits cell-specific targeting needed to suppress primary or metastatic neuroblastoma while avoiding off-target delivery to healthy tissues.
- What they did: The team used SpyTag technology to dose-dependently attach an anti-GD2 scFv to galactose-binding-deficient AAV9-W503A, then tested transduction and therapeutic effects in pseudometastatic and subcutaneous neuroblastoma xenograft mouse models.
- The result: AAV-STITCH-GD2 transduced tumor cells selectively, and suicide gene delivery significantly slowed tumor growth and extended survival; combined with standard-of-care chemotherapy for relapsed neuroblastoma, it produced robust curative effects in mice.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.